Also trades as: ERIS.BO (BSE) · $vol 0M
ERIS.NS NSE
Eris Lifesciences Limited
1W: -6.7%
1M: -8.5%
3M: -16.9%
YTD: -18.8%
1Y: -29.0%
3Y: +49.5%
5Y: +61.9%
₹1,190.80 ($12.36)
-1.10 (-0.09%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$3.5B
-67.4% ▼
5Y CAGR: -1.6%
Capital Expenditures
$3.0B
-91.5% ▼
5Y CAGR: +63.0%
Free Cash Flow
$501M
-94.5% ▼
5Y CAGR: -32.2%
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1.3B
-225.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $4.4B | $4.0B | $3.9B | $3.5B | $6.4B |
| Depreciation & Amort. | $647M | $1.2B | $1.8B | $3.2B | $2.8B |
| Stock-Based Comp. | $14M | $31M | $8M | $91M | $80M |
| Change in Working Capital | -$299M | -$1.8B | -$987M | $1.3B | -$4.6B |
| Other Non-Cash Items | -$24M | $234M | $94M | $2.6B | -$1.2B |
| Operating Cash Flow | $3.8B | $2.9B | $4.9B | $10.7B | $3.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.2B | -$8.4B | -$1.3B | -$1.6B | $0 |
| Acquisitions (Net) | -$103M | -$6.6B | -$5.7B | -$11.7B | -$446M |
| Investment Purchases | -$2.7B | -$300M | $0 | -$514M | -$470M |
| Investment Sales | $796M | $5.2B | $484M | $12.9B | $168M |
| Other Investing | -$960K | $244M | -$12.1B | $84M | -$3.0B |
| Investing Cash Flow | -$3.2B | -$9.8B | -$18.5B | -$800M | -$3.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | $335M | $8.2B | $14.6B | -$4.0B | -$1.1B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$816M | -$999M | $0 | -$1.0B | $0 |
| Other Financing | -$38M | -$321M | -$885M | -$3.9B | -$128M |
| Financing Cash Flow | -$447M | $6.9B | $13.8B | -$8.8B | -$1.2B |
| Net Change in Cash | $140M | $52M | $382M | $1.1B | -$1.3B |
| Cash End of Period | $509M | $560M | $942M | $2.0B | $673M |
| Free Cash Flow | $2.6B | -$5.5B | $3.6B | $9.1B | $501M |